Tamoxifen: Catalyst for the change to targeted therapy

This publication has 93 references indexed in Scilit:

• New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer
  Published by Elsevier ,2007
• Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial
  JAMA, 2006
• Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
  New England Journal of Medicine, 2005
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
  The Lancet, 2005
• A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
  New England Journal of Medicine, 2003
• Tamoxifen: a most unlikely pioneering medicine
  Nature Reviews Drug Discovery, 2003
• CONTROLLED TRIAL OF TAMOXIFEN AS ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST CANCER
  The Lancet, 1983
• Oestrogen-responsive human breast cancer in long term tissue culture
  Nature, 1975
• A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
  British Journal of Cancer, 1971
• A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization.
  Proceedings of the National Academy of Sciences, 1966